A research team at the Queensland University of Technology (QUT) in Australia has discovered a new binding site on the SARS-CoV-2 spike (S) protein, which could be used as a target for anticoagulant drugs.
The prevalence of neural tube defects (NTDs) is 7.0 per 10,000 live births in HIV-exposed pregnancies, which is similar to the prevalence in the general population ...
The research investigates the risk of drug-induced folate deficiency with HIV integrase inhibitors and published in Drug Metabolism and Disposition (DMD)